(1)
Jia, N. Evaluating the Efficacy of Immune Checkpoint Inhibitors Across Different Cancer Types: Focusing on Lung Cancer, Breast Cancer and Melanoma. TMBLS 2025, 8, 39-44. https://doi.org/10.62051/8hkm3p85.